PTPN1 and metabolic disease: The non-receptor tyrosine phosphatase PTPN1 (also known as PTP1B) constitutes the paradigm of PTP enzymes and a suitable drug target for cancer and metabolic diseases [30–33], and PTPN1 protein expression has been shown to correlate with metastasis and poor prognosis in several human cancers [34–37].